<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.34878.007</object-id><label>Table 1.</label><caption><title>Strains used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Strain Abbreviation*</th><th valign="top">Ancestor (source)<sup>&#8224;</sup></th><th valign="top">Genotype</th><th valign="top"># UAG Codons<sup>&#8225;</sup></th><th valign="top">RF1 Status<sup>&#167;</sup></th><th valign="top">Ribosomal rescue gene deletion</th><th valign="top">ssrA tag Status<sup>#</sup></th><th valign="top">Investigated in</th></tr></thead><tbody><tr><td valign="top">GRO.DD.<italic>prfA+</italic></td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>]</td><td valign="top">0</td><td valign="top">+RF1</td><td valign="top">n/a</td><td valign="top">DD</td><td valign="top">GFP expression for mass spectrometry (<xref ref-type="fig" rid="fig2">Figure 2</xref>)</td></tr><tr><td valign="top">GRO.DD</td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">n/a</td><td valign="top">DD</td><td valign="top">GFP expression for mass spectrometry (<xref ref-type="fig" rid="fig2">Figure 2</xref>)</td></tr><tr><td valign="top">ECNR2.AA</td><td valign="top"><italic>E. coli</italic> MG1655 (<xref ref-type="bibr" rid="bib69">Wang et al., 2009</xref>)</td><td valign="top">MG1655 &#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>]</td><td valign="top">321</td><td valign="top">+RF1</td><td valign="top">n/a</td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr><tr><td valign="top">GRO.AA</td><td valign="top">ECNR2.AA (<xref ref-type="bibr" rid="bib39">Lajoie et al., 2013b</xref>)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">n/a</td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr><tr><td valign="top">GRO.AA.&#8710;<italic>ssrA</italic></td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">&#8710;<italic>ssrA</italic></td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr><tr><td valign="top">GRO.AA.&#8710;<italic>arfA</italic></td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">&#8710;<italic>arfA</italic></td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr><tr><td valign="top">GRO.AA.&#8710;<italic>arfB</italic></td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">&#8710;<italic>arfB</italic></td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr><tr><td valign="top">GRO.AA.&#8710;<italic>ssrA.</italic>&#8710;<italic>arfB</italic></td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">&#8710;<italic>ssrA,</italic> &#8710;<italic>arfB</italic></td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr><tr><td valign="top">GRO.AA.&#8710;<italic>arfA.</italic> &#8710;<italic>arfB</italic></td><td valign="top">GRO.AA (this study)</td><td valign="top">&#916;<italic>mutS</italic>:<italic>zeo</italic>.&#916;(<italic>ybhB-bioAB</italic>):[&#955;cI857.&#916;(<italic>cro-ea59</italic>):<italic>tetR-bla</italic>], &#916;<italic>prfA</italic>, &#916;<italic>tolC</italic></td><td valign="top">0</td><td valign="top">&#8710;RF1</td><td valign="top">&#8710;<italic>arfA,</italic> &#8710;<italic>arfB</italic></td><td valign="top">AA</td><td valign="top">Fitness, conjugation, and viral infection (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>)</td></tr></tbody></table><table-wrap-foot><fn><p>*All strains derived from ECNR2, as described in <xref ref-type="bibr" rid="bib69">Wang et al. (2009)</xref>.</p><p>&#8224;See <bold>Key Resources Table</bold> for additional information on strains and sources. The GenBank accession number for <italic>E. coli</italic> MG1655 is U00096, and the GenBank accession number for GRO.AA is CP006698.</p></fn><fn><p>&#8225; Out of a total of 321 in the original ECNR2 strain.</p><p>&#167;RF1 terminates translation at UAG and UAA. Deletion of RF1 eliminates recognition of UAG during translation; translational termination continues through RF2, which recognizes UAA and UGA.</p></fn><fn><p>#The <italic>ssrA</italic> gene encodes the tmRNA, which appends the <italic>ssrA</italic> degradation tag to stalled ribosomes. The wild-type sequence is AANDENYAL<bold><underline>AA</underline></bold>; mutation of the C-terminus to AANDENYAL<bold><underline>DD</underline></bold> slows degradation of peptides to enable detection by mass spectrometry.</p></fn></table-wrap-foot></table-wrap>